Allovir Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ALVR Nasdaq 8731 https://www.allovir.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Allovir Inc

AlloVir to Present at the Piper Sandler 35th Annual Healthcare Conference - Nov 16th, 2023 12:00 pm
AlloVir Inc (ALVR) Reports Q3 2023 Financial Results - Nov 2nd, 2023 2:04 pm
AlloVir Reports Third Quarter 2023 Financial Results - Nov 2nd, 2023 11:00 am
Why AlloVir Stock Dropped Today - Sep 21st, 2023 6:44 pm
We're Keeping An Eye On AlloVir's (NASDAQ:ALVR) Cash Burn Rate - Sep 15th, 2023 12:53 pm
These 2 “Strong Buy” Penny Stocks Could Soar to $17 (Or Higher), Say Analysts - Sep 14th, 2023 1:59 pm
AlloVir to Present at Upcoming Investor Conferences - Aug 28th, 2023 11:00 am
AlloVir Reports Second Quarter 2023 Financial Results - Aug 3rd, 2023 11:00 am
Eliem (ELYM) to Explore Strategic Options, Stock Rises 6% - Jul 21st, 2023 11:17 am
Journey Medical (DERM) to Post Skin Disease Data, Stock Rises 26% - Jul 4th, 2023 11:34 am
AlloVir, Inc. (ALVR) Upgraded to Buy: Here's Why - Jun 27th, 2023 4:00 pm
Why Shares of AlloVir Plummeted This Week - Jun 23rd, 2023 5:56 pm
AlloVir Announces Pricing of Public Offering of Common Stock - Jun 22nd, 2023 1:20 am
AlloVir Announces Proposed Public Offering of Common Stock - Jun 21st, 2023 8:18 pm
Why Shares of AlloVir Jumped This Week - Jun 9th, 2023 3:04 pm
AlloVir Presents Positive Final Results From A Phase 2 Randomized, Placebo-Controlled Trial Evaluating Posoleucel Treatment of BK Infection in Kidney Transplant Recipients at the American Transplant Congress (ATC 2023) - Jun 5th, 2023 11:00 am
AlloVir Announces Appointment of Cintia Piccina, PharmD, MBA, as Chief Commercial Officer - May 16th, 2023 11:00 am
AlloVir Reports First Quarter 2023 Financial Results - May 4th, 2023 11:00 am
AlloVir to Present at the BofA Securities 2023 Health Care Conference - May 1st, 2023 11:00 am
AlloVir's Posoleucel Achieves Non-Relapse Mortality Of 0% In Transplant Patients For Viral Infections - Apr 26th, 2023 9:12 pm